Ehrlichiosis pathophysiology

Revision as of 17:00, 6 August 2015 by Shanshan Cen (talk | contribs)
Jump to navigation Jump to search

Ehrlichiosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ehrlichiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Ehrlichiosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ehrlichiosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ehrlichiosis pathophysiology

CDC on Ehrlichiosis pathophysiology

Ehrlichiosis pathophysiology in the news

Blogs on Ehrlichiosis pathophysiology

Directions to Hospitals Treating Ehrlichiosis

Risk calculators and risk factors for Ehrlichiosis pathophysiology

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Pathophysiology

  • Ehrlichia are transported between cells through the host cell filopodia during initial stages of infection, whereas, in the final stages of infection the pathogen ruptures the host cell membrane.[1]
  • Most of the symptoms of Ehrlichiosis can likely be ascribed to the immune dysregulation that it causes.
  • Early in infection, production of TNF-alpha, a cellular product that promotes inflammation and immune response, is suppressed. Experiments in mouse models further supports this hypothesis, as mice lacking TNF-alpha I/II receptors are resistant to liver injury caused by ehrlichia infection.[2]
  • Late in infection, however, production of this substance can be upregulated by 30 fold, which is likely responsible for the "toxic shock-like" syndrome seen in some severe cases of ehrlichiosis.

References

  1. Thomas S, Popov VL, Walker DH (2010). Kaushal, Deepak, ed. "Exit Mechanisms of the Intracellular Bacterium Ehrlichia". PLoS ONE. 5 (12): e15775. doi:10.1371/journal.pone.0015775. PMC 3004962. PMID 21187937.
  2. McBride, Jere W. (31 January 2011). "Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies". Expert Reviews in Molecular Medicine. 13. doi:10.1017/S1462399410001730. Unknown parameter |coauthors= ignored (help)